CELZ
Creative Medical Technology Holdings, Inc.Company with tickers: CELZ
CIK
1187953
CUSIP
22529Y408
Shares Outstanding
3,696,668
13F Activity (30d)
12 filings
10 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $0 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Gross Profit | $0 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Expenses | $1,459,153 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Research & Development | $541,658 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-1,459,153 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-1,405,077 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | $-0.38 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |